Home  »  Pharmaceutical

Pharmaceutical Market Research Reports

China Pharmaceutical Distribution Industry Report, 2013
Thanks to the continuous advancement in new medical reform, China’s pharmaceutical distribution industry has maintained a fairly rapid growth in recent years, with the sales value showed a CAGR of roughly 20% in 2005-2013. As the leading players in China’s pharmaceutical distribution industry, Shanghai Pharma, Jointown and China National Accord Medicines achieved the revenue of RMB58.1 billion , RMB24.8 billion , RMB15.8 billion, respectively, in the first three quarters of 2013. In terms of drug categories, western medicine constitutes the first major category in Chinese medicine distribution market, accounting for approximately 70% of total revenue from Chinese pharmaceutical products during 2012-2013. Then what comes the next are Chinese patent medicine and traditional Ch
Published Date: Apr 2014
Published By: Research In China

Price: $2400
Global and China Insulin Industry 2014 Deep Research Report
The report firstly introduced Insulin basic information included Insulin definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Insulin industry policy and plan, Insulin product specification, manufacturing process, product cost structure etc. then statistics Global and China key manufacturers Insulin capacity production cost price Gross production value gross margin etc details information, at the same time, statistics these manufacturers Insulin products customers application capacity market position company contact information etc company related information, then collect all these manufacturers data and listed Global and Ch
Published Date: Apr 2014
Published By: QYResearch

Price: $2200
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Malaysia
Healthcare, Regulatory and Reimbursement Landscape  Malaysia. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Malaysia. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and inhouse analysis by GlobalDatas team of industry experts. In 2013, Malaysias population stood at 29.9 million. The past five years have seen steady population growth, which is expected to co
Published Date: Apr 2014
Published By: GlobalData

Price: $1995
The Pharmaceutical Market: Greece
THE PHARMACEUTICAL MARKET: GREECE - REVIEW The immediate threat of a Greek default and eurozone exit was reduced as the outcome of the legislative elections in June had a much more benign outcome than many feared. A n exit would have - and could still be - disastrous for drugmakers operating in the market. But even Greece staying in the monetary union means the government must continue with its austerity programme. While we continue to hold to our view that Germany and the rest of the EU may reduce the focus on austerity and introduce some pro-growth strategies, these are unlikely to generate any upside for the pharmaceutical industry and structural reforms within Greece will be maintained. T he government remains committed to huge cuts in its public drug expenditure for 2012, with a
Published Date: Apr 2014
Published By: Espicom

Price: $1295
The Pharmaceutical Market: Bahrain
Pharmaceuticals & Healthcare Report We expect Bahrain\'s pharmaceutical market values to grow steadily over the coming years. Key drivers will be volume-based, as the growing population increasingly requires more sophisticated treatments for lifestyle diseases and as healthcare provision expands and modernises . However, w hile some investment has been made into the local pharmaceutical manufacturing industry, imports will continue to supply the bulk of the demand. Headline Expenditure Projections Pharmaceuticals: BHD90mn (US$240mn) in 2011 to BHD100mn (US$260mn) in 2012; +6.12% in both local currency and US dollar terms. Forecastunchanged from Q412. Healthcare: BHD420mn (US$1.1bn) in 2011 to BHD500mn (US$1.2bn); +7.3% in both local currency and US dollar terms. Forecastu
Published Date: Apr 2014
Published By: Espicom

Price: $1295
The Pharmaceutical Market: Cambodia
Cambodia Pharmaceuticals & Healthcare Report Lacklustre efforts by the government to boost healthcare means that the Cambodia will be the least attractive to pharmaceutical investors as compared to its South East Asian peers as the population are unable to afford new treatments. Over the longer term we expect such trends to change and active participation in the Association of Southeast Asia Nations (ASEAN) Economic Community will boost its attractiveness. Headline Expenditure Projections Pharmaceuticals: KHR718bn (US$178mn) in 2011 to KHR806bn (US$193mn) in 2012; +12.2% in local currency terms and +8.8% in US dollar terms. Growthforecast unchanged from Q312, although we have adjusted the absolute value following reassessment of the market size. Healthcare: KHR2,982bn (US
Published Date: Apr 2014
Published By: Espicom

Price: $1295
The Pharmaceutical Market: Sri Lanka
Sri Lanka Pharmaceuticals & Healthcare Report Sri Lanka\'s negative pharmaceutical trade balance is expected to widen over the next five years. In an attempt to reduce medical costs, the government said in its 2011 budget that pharmaceutical products will be exempt from the port and airport levy, with the changes relating to drugs, medical devices and equipment. Although domestic manufacturing will struggle to compete with cheap medicines from India, we expect local producers to increase capacity considerably over the medium term. Headline Expenditure Projections Pharmaceuticals: LKR50.68bn (US$458mn) in 2011 to LKR59.90bn (US$501mn) in 2012; +18.2% in local currency terms and +9.4% in US dollar terms. Healthcare: LRK250.62bn (US$2.27bn) in 2011 to LKR278.82bn (US$2.34bn)
Published Date: Apr 2014
Published By: Espicom

Price: $1295
Chelating Agents (APCA, Sodium Gluconate, Organophosphates and Others) Market For Pulp & Paper, Household & Industrial Cleaning, Agrochemicals, Water Treatment, Chemical Processing, Consumer Products and Other Applications - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
Chelating agents are high performance chemical substances which are used to prevent the deleterious effects of metal ions by forming metal-ion complexes. They are used in a wide array of applications including household & industrial cleaning, pulp & paper, chemical processing and agrochemicals among others. APCAs, gluconates and organophosphonates are certain majorly used chelating agents across various industries.  The report on chelating agents provides a detailed analysis and forecast of the market on a global as well as regional level for a time period ranging between 2013 and 2019. On a global level, the market has been segmented on the basis of volume (kilo tons) and revenue (USD million) for a period of time ranging from 2013 to 2019. For an in-depth understanding
Published Date: Apr 2014
Published By: Transparency Market Research

Price: $4795
The Pharmaceutical Market: Czech Republic
OVERVIEW OF THE PHARMACEUTICAL MARKET IN CZECH REPUBLIC The recent measures proposed by the Czech Republic\'s Ministry of Health will, in all likelihood, negatively affect the Czech pharmaceutical market. The introduction of reimbursement ceilings, blind bidding auctions and preferential prescribing will squeeze drugmakers\' margins and shift some of the burden of healthcare spending onto the private sector. The outcome of similar measures in Hungary and Poland strongly supports our view that the business environment for drugmakers will worsen if these proposals are adopted. It is patients who, ultimately, will suffer. Headline Expenditure Projections Pharmaceuticals: CZK80.71bn (US$4.56bn) in 2011 to CZK79.76bn (US$4.2bn) in 2012; -1.2% in local currency terms and -7.1% in US d
Published Date: Apr 2014
Published By: Espicom

Price: $1295
The Pharmaceutical Market: Denmark
OVERVIEW OF THE PHARMACEUTICAL MARKET IN DENMARK The macroenvironment for the Danish pharmaceutical industry is improving. The centre-left coalition, of the Social Democratic Party, the Socialist People\'s Party and the Social Liberal Party, took office in October 2011. Denmark suffered a deep recession and economic recovery is stalling with negative GDP growth projected for 2012. Denmark has an ageing population, and the Economist Intelligence Unit projects that the population aged 65 and over will constitute more than one-fifth of the total population by 2016. As a result, healthcare is increasingly focused on preventative care and there will be a continuing demand for new therapies so that patients can be treated more effectively. The increasing pharmaceutical expenditure in Den
Published Date: Apr 2014
Published By: Espicom

Price: $1295
Synthetic Biology Market (Synthetic DNA, Synthetic Genes, Synthetic Cells, XNA, Chassis Organisms, DNA Synthesis, Oligonucleotide Synthesis) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast,2013 - 2019
Synthetic biology defined as the synthesis of artificial or natural components in order to form new artificial living system by re-molding existing biological elements. It aims to attain new preferred functions of artificially modified organisms intended for high yield production of biological systems. Synthetic biology plays an important role in the field of life sciences by developing cheap synthesis procedures. Increasing scientific research coupled with introduction of advanced technologies in synthetic biology will drive the growth of this market. The market for synthetic biology is segmented as: by products, by technologies and by applications. Product segment includes core products and enabling products. Core product segment comprises synthetic DNA, synthetic genes, synthetic cell
Published Date: Apr 2014
Published By: Transparency Market Research

Price: $4795
The Pharmaceutical Market: Venezuela
OVERVIEW OF THE PHARMACEUTICAL MARKET IN VENEZUELA We expect the Venezuelan government to continue its foreign currency and import control policies in Q412 and the local market will endure further government restrictions on pharmaceutical and healthcare industry. Multinationals will have the potential revenue-generation opportunities from Venezuela\'s increasing reliance on imported products to meet local demand, as the election outcome will not fix the production capacity issues in the domestic industry. Headline Expenditure Projections Pharmaceuticals: VEB33.26bn (US$5.46bn) in 2011 to VEB40.77bn (US$6.00bn) in 2012; +22.6% in local currency terms and +10.0% in US dollar terms. Forecasts down due to new industrial information. Healthcare: VEB66.69bn (US$10.94bn) in 2011 to
Published Date: Apr 2014
Published By: Espicom

Price: $1295
The Pharmaceutical Market: Iraq
OVERVIEW OF THE PHARMACEUTICAL MARKET IN IRAQ Years of underinvestment have taken their toll on the Iraqi healthcare market, as have international sanctions and deterioration of healthcare infrastructure due to war. Still an unpopular figure on the international market, Iraq\'s trade partners are few and far between - although Iraq does have a strong bargaining chip: its oil resources. Healthcare facilities are gradually improving, with plans for new hospitals such as two specialist hospitals planned in partnership with Iran\'sRed Crescent organisation. But access to funding is limited, import and exports are restricted, and the country has a severe shortage of trained medical professionals. As such, it is of little surprise that there are few distinctions in the market between OTC an
Published Date: Apr 2014
Published By: Espicom

Price: $1295
The Pharmaceutical Market: Lithuania
THE PHARMACEUTICAL MARKET: LITHUANIA- REVIEW We continue to hold our subdued outlook for the Lithuanian pharmaceuticals market during the next few years, on account of the changing economic and demographic situation. We expect limited low single digit growth in 2012 , with the market expected to increase by a local currency margin of 2.5% year-on-year (y-o-y) to reach LTL1.6 8 bn (US$6 18 mn) in 2012 at consumer prices. However, in US dollar terms, the market \' s value will shrink by 6.3%, in dicating the challenges facing companies operating in the market . Headline Expenditure Projections Pharmaceuticals: LTL1.64bn (US$659mn) in 2011 to LTL1.68bn (US$618mn) in 2012; +2.5% in local currency terms and -6.3% in US dollar terms. Forecastslightly upfrom Q4 12on account of new
Published Date: Apr 2014
Published By: Espicom

Price: $1295
China Pharmaceutical Glass Packaging Industry Report, 2013-2016
Influenced by the substitution of plastic, aluminum foil and other new packaging materials as well as the declining packaging material purchase prices incurred by the medical reform, China pharmaceutical glass packaging industry develops sluggishly. In 2013, China’s pharmaceutical glass bottle market capacity amounted to 80 billion pieces with the weight of 250,000-300,000 tons. Due to low entry barriers, Chinese pharmaceutical glass market is featured with serious overcapcity of medium and low-end products as well as the reliance of high-end products on imports. At present, developed countries prefer first-class waterproof neutral borosilicate glass, while China still in the main applies low borosilicate glass, sodium-calcium glass and \"semi-neutral borosilicate glass\" (its c
Published Date: Apr 2014
Published By: Research In China

Price: $1500
EpiCast Report: Allergic Rhinitis - Epidemiology Forecast to 2023
Allergic rhinitis is a chronic respiratory disease characterized by inflammation of the nasal cavity and affects people of all ages. The main symptoms of allergic rhinitis are sneezing, nasal itching, blocked or runny nose and sore throat. Research suggests that a combination of genetic factors such as family history of allergic rhinitis and environmental factors such as exposure to allergens, including smoke, dust, pollen, insects, molds, or animal dander, may increase the risk for developing allergic rhinitis. According to the World Health Organization, an estimated 400 million people worldwide were affected with  allergic rhinitis during 1996-2006. According to GlobalData\'s epidemiological forecast, the total prevalent cases of allergic  rhinitis in the 7MM will increa
Published Date: Apr 2014
Published By: GlobalData

Price: $3995
The Pharmaceutical Market: Saudi Arabia
OVERVIEW OF THE PHARMACEUTICAL MARKET IN SAUDI ARABIA Saudi Arabia\' s transition to an increasingly privatised and comprehensive healthcare system will drive the demand for both patented and generic drugs . The country is investing heavily in healthcare infrastructure and we expect this will be borne out in double-digit growth forecasts across our three headline indicators. Headline Expenditure Projections Pharmaceuticals: SAR16.70bn (US$4.46bn) in 2011 to SAR18.95bn (US$5.06bn) in 2012; +13.5% in local currency and US dollar terms. Forecastbroadly unchanged from Q3 12. Healthcare: SAR78.63bn (US$21.00bn) in 2011 to SAR91.20bn (US$24.35bn) in 2012; +16.0% in local currency and US dollar terms. Forecast broadly unchanged from Q3 12. Medicaldevices: SAR5.54bn (US$1.48bn) in
Published Date: Apr 2014
Published By: Espicom

Price: $1295
The Pharmaceutical Market: Morocco
OVERVIEW OF THE PHARMACEUTICAL MARKET IN MOROCCO Morocco\'s subsidised health insurance scheme,Régime d\'Assistance Médicale (RAMED),launched in March 2012,is experiencing early-stage difficulties with its target to increasehealthcare accessibilityto those on low incomes. This is to be expected, given the evidence of bribery and corruption, and the shortage of doctors in the sector.BMIbelievesthe commitment to improvegovernance and implement controls in the sector will be fulfilled in the medium-to-longterm. As such, we maintainthat government healthcare spending will outpace private healthcare spending over the forecast 2011-2016 period. Headline Expenditure Projections Pharmaceuticals: MAD10.10bn (US$1.25bn) in 2011 to MAD11.24bn (US$1.30bn) in 2012; +11.3% i
Published Date: Apr 2014
Published By: Espicom

Price: $1295
The Pharmaceutical Market: Serbia
OVERVIEW OF THE PHARMACEUTICAL MARKET IN SERBIA While the market is small in terms of absolute numbers, relative per capita spending on medicines is expected to improve over the long term. As the country continues its economic convergence with developed Europe, drug consumption is also expected to rise. However, financial inefficiencies within the health insurance system mean that the National Health Insurance Institution ( RZZO ) is unable to always meet its obligations on time, leaving patients to pay for formerly reimbursed medicines or hospitals having to cover the difference . Headline Expenditure Projections Pharmaceuticals: RSD75.70bn (US$1.03bn) in 2011 to RSD81.44bn (US$0.92bn) in 2012; +7.6% in local currency terms and -11.0% in US dollar terms. Healthcare: RSD347.7
Published Date: Apr 2014
Published By: Espicom

Price: $1295
2014 Market Research Report on Global Berberine Industry
was a professional and depth research report on Global Berberine industry that you would know the world's major regional market conditions of Berberine industry, the main region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc.The report firstly introduced Berberine basic information including Berberine definition classification application and industry chain overview; Berberine industry policy and plan, Berberine product specification, manufacturing process, cost structure etc. Then we deeply analyzed the world's main region market conditions that including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc.In the end, the report introduced Berberine ne
Published Date: Mar 2014
Published By: 9Dimen Research

Price: $2850
2014 Market Research Report on Global Metronidazole Industry
was a professional and depth research report on Global Metronidazole industry that you would know the world's major regional market conditions of Metronidazole industry, the main region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc.The report firstly introduced Metronidazole basic information including Metronidazole definition classification application and industry chain overview; Metronidazole industry policy and plan, Metronidazole product specification, manufacturing process, cost structure etc. Then we deeply analyzed the world's main region market conditions that including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc.In the end, the report
Published Date: Mar 2014
Published By: 9Dimen Research

Price: $2850
2014 Market Research Report on Global Furazolidone Industry
was a professional and depth research report on Global Furazolidone industry that you would know the world's major regional market conditions of Furazolidone industry, the main region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc.The report firstly introduced Furazolidone basic information including Furazolidone definition classification application and industry chain overview; Furazolidone industry policy and plan, Furazolidone product specification, manufacturing process, cost structure etc. Then we deeply analyzed the world's main region market conditions that including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc.In the end, the report intro
Published Date: Mar 2014
Published By: 9Dimen Research

Price: $2850
2014 Market Research Report on Global Ciprofloxacin Industry
was a professional and depth research report on Global Ciprofloxacin industry that you would know the world's major regional market conditions of Ciprofloxacin industry, the main region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc.The report firstly introduced Ciprofloxacin basic information including Ciprofloxacin definition classification application and industry chain overview; Ciprofloxacin industry policy and plan, Ciprofloxacin product specification, manufacturing process, cost structure etc. Then we deeply analyzed the world's main region market conditions that including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc.In the end, the report
Published Date: Mar 2014
Published By: 9Dimen Research

Price: $2850
2014 Market Research Report on Global Ofloxacin Industry
was a professional and depth research report on Global Ofloxacin industry that you would know the world's major regional market conditions of Ofloxacin industry, the main region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc.The report firstly introduced Ofloxacin basic information including Ofloxacin definition classification application and industry chain overview; Ofloxacin industry policy and plan, Ofloxacin product specification, manufacturing process, cost structure etc. Then we deeply analyzed the world's main region market conditions that including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc.In the end, the report introduced Ofloxacin ne
Published Date: Mar 2014
Published By: 9Dimen Research

Price: $2850
2014 Market Research Report on Global Norfloxacin Industry
was a professional and depth research report on Global Norfloxacin industry that you would know the world's major regional market conditions of Norfloxacin industry, the main region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc.The report firstly introduced Norfloxacin basic information including Norfloxacin definition classification application and industry chain overview; Norfloxacin industry policy and plan, Norfloxacin product specification, manufacturing process, cost structure etc. Then we deeply analyzed the world's main region market conditions that including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc.In the end, the report introduced
Published Date: Mar 2014
Published By: 9Dimen Research

Price: $2850
2014 Market Research Report on Global Cotrimoxazole Industry
was a professional and depth research report on Global Cotrimoxazole industry that you would know the world's major regional market conditions of Cotrimoxazole industry, the main region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc.The report firstly introduced Cotrimoxazole basic information including Cotrimoxazole definition classification application and industry chain overview; Cotrimoxazole industry policy and plan, Cotrimoxazole product specification, manufacturing process, cost structure etc. Then we deeply analyzed the world's main region market conditions that including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc.In the end, the report
Published Date: Mar 2014
Published By: 9Dimen Research

Price: $2850
2014 Market Research Report on Global Sulfadiazine Industry
was a professional and depth research report on Global Sulfadiazine industry that you would know the world's major regional market conditions of Sulfadiazine industry, the main region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc.The report firstly introduced Sulfadiazine basic information including Sulfadiazine definition classification application and industry chain overview; Sulfadiazine industry policy and plan, Sulfadiazine product specification, manufacturing process, cost structure etc. Then we deeply analyzed the world's main region market conditions that including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc.In the end, the report intro
Published Date: Mar 2014
Published By: 9Dimen Research

Price: $2850
2014 Market Research Report on Global Clindamycin Industry
was a professional and depth research report on Global Clindamycin industry that you would know the world's major regional market conditions of Clindamycin industry, the main region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc.The report firstly introduced Clindamycin basic information including Clindamycin definition classification application and industry chain overview; Clindamycin industry policy and plan, Clindamycin product specification, manufacturing process, cost structure etc. Then we deeply analyzed the world's main region market conditions that including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc.In the end, the report introduced
Published Date: Mar 2014
Published By: 9Dimen Research

Price: $2850
2014 Market Research Report on Global Lincomycin Industry
was a professional and depth research report on Global Lincomycin industry that you would know the world's major regional market conditions of Lincomycin industry, the main region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc.The report firstly introduced Lincomycin basic information including Lincomycin definition classification application and industry chain overview; Lincomycin industry policy and plan, Lincomycin product specification, manufacturing process, cost structure etc. Then we deeply analyzed the world's main region market conditions that including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc.In the end, the report introduced Lincom
Published Date: Mar 2014
Published By: 9Dimen Research

Price: $2850
2014 Market Research Report on Global Amber chloramphenicol Industry
was a professional and depth research report on Global Amber chloramphenicol industry that you would know the world's major regional market conditions of Amber chloramphenicol industry, the main region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc.The report firstly introduced Amber chloramphenicol basic information including Amber chloramphenicol definition classification application and industry chain overview; Amber chloramphenicol industry policy and plan, Amber chloramphenicol product specification, manufacturing process, cost structure etc. Then we deeply analyzed the world's main region market conditions that including the product price, profit, capacity, production, capacity utilization, supply, demand and
Published Date: Mar 2014
Published By: 9Dimen Research

Price: $2850
2014 Market Research Report on Global Chloromycetin Industry
was a professional and depth research report on Global Chloromycetin industry that you would know the world's major regional market conditions of Chloromycetin industry, the main region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc.The report firstly introduced Chloromycetin basic information including Chloromycetin definition classification application and industry chain overview; Chloromycetin industry policy and plan, Chloromycetin product specification, manufacturing process, cost structure etc. Then we deeply analyzed the world's main region market conditions that including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc.In the end, the report
Published Date: Mar 2014
Published By: 9Dimen Research

Price: $2850
2014 Market Research Report on Global Doxycycline Industry
was a professional and depth research report on Global Doxycycline industry that you would know the world's major regional market conditions of Doxycycline industry, the main region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc.The report firstly introduced Doxycycline basic information including Doxycycline definition classification application and industry chain overview; Doxycycline industry policy and plan, Doxycycline product specification, manufacturing process, cost structure etc. Then we deeply analyzed the world's main region market conditions that including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc.In the end, the report introduced
Published Date: Mar 2014
Published By: 9Dimen Research

Price: $2850
2014 Market Research Report on Global Oxytetracycline Industry
was a professional and depth research report on Global Oxytetracycline industry that you would know the world's major regional market conditions of Oxytetracycline industry, the main region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc.The report firstly introduced Oxytetracycline basic information including Oxytetracycline definition classification application and industry chain overview; Oxytetracycline industry policy and plan, Oxytetracycline product specification, manufacturing process, cost structure etc. Then we deeply analyzed the world's main region market conditions that including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc.In the end
Published Date: Mar 2014
Published By: 9Dimen Research

Price: $2850
2014 Market Research Report on Global Tetracycline Industry
was a professional and depth research report on Global Tetracycline industry that you would know the world's major regional market conditions of Tetracycline industry, the main region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc.The report firstly introduced Tetracycline basic information including Tetracycline definition classification application and industry chain overview; Tetracycline industry policy and plan, Tetracycline product specification, manufacturing process, cost structure etc. Then we deeply analyzed the world's main region market conditions that including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc.In the end, the report intro
Published Date: Mar 2014
Published By: 9Dimen Research

Price: $2850
2014 Market Research Report on Global Josamycin Industry
was a professional and depth research report on Global Josamycin industry that you would know the world's major regional market conditions of Josamycin industry, the main region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc.The report firstly introduced Josamycin basic information including Josamycin definition classification application and industry chain overview; Josamycin industry policy and plan, Josamycin product specification, manufacturing process, cost structure etc. Then we deeply analyzed the world's main region market conditions that including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc.In the end, the report introduced Josamycin ne
Published Date: Mar 2014
Published By: 9Dimen Research

Price: $2850
2014 Market Research Report on Global Spiramycin Industry
was a professional and depth research report on Global Spiramycin industry that you would know the world's major regional market conditions of Spiramycin industry, the main region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc.The report firstly introduced Spiramycin basic information including Spiramycin definition classification application and industry chain overview; Spiramycin industry policy and plan, Spiramycin product specification, manufacturing process, cost structure etc. Then we deeply analyzed the world's main region market conditions that including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc.In the end, the report introduced Spiram
Published Date: Mar 2014
Published By: 9Dimen Research

Price: $2850
2014 Market Research Report on Global Midecamycin Industry
was a professional and depth research report on Global Midecamycin industry that you would know the world's major regional market conditions of Midecamycin industry, the main region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc.The report firstly introduced Midecamycin basic information including Midecamycin definition classification application and industry chain overview; Midecamycin industry policy and plan, Midecamycin product specification, manufacturing process, cost structure etc. Then we deeply analyzed the world's main region market conditions that including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc.In the end, the report introduced
Published Date: Mar 2014
Published By: 9Dimen Research

Price: $2850
2014 Market Research Report on Global Dirithromycin Industry
was a professional and depth research report on Global Dirithromycin industry that you would know the world's major regional market conditions of Dirithromycin industry, the main region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc.The report firstly introduced Dirithromycin basic information including Dirithromycin definition classification application and industry chain overview; Dirithromycin industry policy and plan, Dirithromycin product specification, manufacturing process, cost structure etc. Then we deeply analyzed the world's main region market conditions that including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc.In the end, the report
Published Date: Mar 2014
Published By: 9Dimen Research

Price: $2850
2014 Market Research Report on Global Clarithromycin Industry
was a professional and depth research report on Global Clarithromycin industry that you would know the world's major regional market conditions of Clarithromycin industry, the main region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc.The report firstly introduced Clarithromycin basic information including Clarithromycin definition classification application and industry chain overview; Clarithromycin industry policy and plan, Clarithromycin product specification, manufacturing process, cost structure etc. Then we deeply analyzed the world's main region market conditions that including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc.In the end, the
Published Date: Mar 2014
Published By: 9Dimen Research

Price: $2850
2014 Market Research Report on Global Azithromycin Industry
was a professional and depth research report on Global Azithromycin industry that you would know the world's major regional market conditions of Azithromycin industry, the main region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc.The report firstly introduced Azithromycin basic information including Azithromycin definition classification application and industry chain overview; Azithromycin industry policy and plan, Azithromycin product specification, manufacturing process, cost structure etc. Then we deeply analyzed the world's main region market conditions that including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc.In the end, the report intro
Published Date: Mar 2014
Published By: 9Dimen Research

Price: $2850
2014 Market Research Report on Global Amikacin Industry
was a professional and depth research report on Global Amikacin industry that you would know the world's major regional market conditions of Amikacin industry, the main region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc.The report firstly introduced Amikacin basic information including Amikacin definition classification application and industry chain overview; Amikacin industry policy and plan, Amikacin product specification, manufacturing process, cost structure etc. Then we deeply analyzed the world's main region market conditions that including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc.In the end, the report introduced Amikacin new proje
Published Date: Mar 2014
Published By: 9Dimen Research

Price: $2850
2014 Market Research Report on Global Kanamycin Industry
was a professional and depth research report on Global Kanamycin industry that you would know the world's major regional market conditions of Kanamycin industry, the main region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc.The report firstly introduced Kanamycin basic information including Kanamycin definition classification application and industry chain overview; Kanamycin industry policy and plan, Kanamycin product specification, manufacturing process, cost structure etc. Then we deeply analyzed the world's main region market conditions that including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc.In the end, the report introduced Kanamycin ne
Published Date: Mar 2014
Published By: 9Dimen Research

Price: $2850
2014 Market Research Report on Global Streptomycin Industry
was a professional and depth research report on Global Streptomycin industry that you would know the world's major regional market conditions of Streptomycin industry, the main region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc.The report firstly introduced Streptomycin basic information including Streptomycin definition classification application and industry chain overview; Streptomycin industry policy and plan, Streptomycin product specification, manufacturing process, cost structure etc. Then we deeply analyzed the world's main region market conditions that including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc.In the end, the report intro
Published Date: Mar 2014
Published By: 9Dimen Research

Price: $2850
2014 Market Research Report on Global Cefoperazone Industry
was a professional and depth research report on Global Cefoperazone industry that you would know the world's major regional market conditions of Cefoperazone industry, the main region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc.The report firstly introduced Cefoperazone basic information including Cefoperazone definition classification application and industry chain overview; Cefoperazone industry policy and plan, Cefoperazone product specification, manufacturing process, cost structure etc. Then we deeply analyzed the world's main region market conditions that including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc.In the end, the report intro
Published Date: Mar 2014
Published By: 9Dimen Research

Price: $2850
2014 Market Research Report on Global Gentamicin Industry
was a professional and depth research report on Global Gentamicin industry that you would know the world's major regional market conditions of Gentamicin industry, the main region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc.The report firstly introduced Gentamicin basic information including Gentamicin definition classification application and industry chain overview; Gentamicin industry policy and plan, Gentamicin product specification, manufacturing process, cost structure etc. Then we deeply analyzed the world's main region market conditions that including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc.In the end, the report introduced Gentam
Published Date: Mar 2014
Published By: 9Dimen Research

Price: $2850
2014 Market Research Report on Global Cefotaxime Industry
was a professional and depth research report on Global Cefotaxime industry that you would know the world's major regional market conditions of Cefotaxime industry, the main region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc.The report firstly introduced Cefotaxime basic information including Cefotaxime definition classification application and industry chain overview; Cefotaxime industry policy and plan, Cefotaxime product specification, manufacturing process, cost structure etc. Then we deeply analyzed the world's main region market conditions that including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc.In the end, the report introduced Cefota
Published Date: Mar 2014
Published By: 9Dimen Research

Price: $2850
2014 Market Research Report on Global Ceftriaxone Industry
was a professional and depth research report on Global Ceftriaxone industry that you would know the world's major regional market conditions of Ceftriaxone industry, the main region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc.The report firstly introduced Ceftriaxone basic information including Ceftriaxone definition classification application and industry chain overview; Ceftriaxone industry policy and plan, Ceftriaxone product specification, manufacturing process, cost structure etc. Then we deeply analyzed the world's main region market conditions that including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc.In the end, the report introduced
Published Date: Mar 2014
Published By: 9Dimen Research

Price: $2850
2014 Market Research Report on Global Cefuroxime Industry
was a professional and depth research report on Global Cefuroxime industry that you would know the world's major regional market conditions of Cefuroxime industry, the main region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc.The report firstly introduced Cefuroxime basic information including Cefuroxime definition classification application and industry chain overview; Cefuroxime industry policy and plan, Cefuroxime product specification, manufacturing process, cost structure etc. Then we deeply analyzed the world's main region market conditions that including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc.In the end, the report introduced Cefuro
Published Date: Mar 2014
Published By: 9Dimen Research

Price: $2850
2014 Market Research Report on Global Cefradine Industry
was a professional and depth research report on Global Cefradine industry that you would know the world's major regional market conditions of Cefradine industry, the main region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc.The report firstly introduced Cefradine basic information including Cefradine definition classification application and industry chain overview; Cefradine industry policy and plan, Cefradine product specification, manufacturing process, cost structure etc. Then we deeply analyzed the world's main region market conditions that including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc.In the end, the report introduced Cefradine ne
Published Date: Mar 2014
Published By: 9Dimen Research

Price: $2850
2014 Market Research Report on Global Cefazolin Industry
was a professional and depth research report on Global Cefazolin industry that you would know the world's major regional market conditions of Cefazolin industry, the main region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc.The report firstly introduced Cefazolin basic information including Cefazolin definition classification application and industry chain overview; Cefazolin industry policy and plan, Cefazolin product specification, manufacturing process, cost structure etc. Then we deeply analyzed the world's main region market conditions that including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc.In the end, the report introduced Cefazolin ne
Published Date: Mar 2014
Published By: 9Dimen Research

Price: $2850
2014 Market Research Report on Global Cephalexin Industry
was a professional and depth research report on Global Cephalexin industry that you would know the world's major regional market conditions of Cephalexin industry, the main region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc.The report firstly introduced Cephalexin basic information including Cephalexin definition classification application and industry chain overview; Cephalexin industry policy and plan, Cephalexin product specification, manufacturing process, cost structure etc. Then we deeply analyzed the world's main region market conditions that including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc.In the end, the report introduced Cephal
Published Date: Mar 2014
Published By: 9Dimen Research

Price: $2850
2014 Market Research Report on Global Oxacillin Industry
was a professional and depth research report on Global Oxacillin industry that you would know the world's major regional market conditions of Oxacillin industry, the main region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc.The report firstly introduced Oxacillin basic information including Oxacillin definition classification application and industry chain overview; Oxacillin industry policy and plan, Oxacillin product specification, manufacturing process, cost structure etc. Then we deeply analyzed the world's main region market conditions that including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc.In the end, the report introduced Oxacillin ne
Published Date: Mar 2014
Published By: 9Dimen Research

Price: $2850
2014 Market Research Report on Global Amoxycillin Industry
was a professional and depth research report on Global Amoxycillin industry that you would know the world's major regional market conditions of Amoxycillin industry, the main region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc.The report firstly introduced Amoxycillin basic information including Amoxycillin definition classification application and industry chain overview; Amoxycillin industry policy and plan, Amoxycillin product specification, manufacturing process, cost structure etc. Then we deeply analyzed the world's main region market conditions that including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc.In the end, the report introduced
Published Date: Mar 2014
Published By: 9Dimen Research

Price: $2850
2014 Market Research Report on Global Ampicillin Industry
was a professional and depth research report on Global Ampicillin industry that you would know the world's major regional market conditions of Ampicillin industry, the main region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc.The report firstly introduced Ampicillin basic information including Ampicillin definition classification application and industry chain overview; Ampicillin industry policy and plan, Ampicillin product specification, manufacturing process, cost structure etc. Then we deeply analyzed the world's main region market conditions that including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc.In the end, the report introduced Ampici
Published Date: Mar 2014
Published By: 9Dimen Research

Price: $2850
2014 Market Research Report on Global Penicillin G Industry
was a professional and depth research report on Global Penicillin G industry that you would know the world's major regional market conditions of Penicillin G industry, the main region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc.The report firstly introduced Penicillin G basic information including Penicillin G definition classification application and industry chain overview; Penicillin G industry policy and plan, Penicillin G product specification, manufacturing process, cost structure etc. Then we deeply analyzed the world's main region market conditions that including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc.In the end, the report intro
Published Date: Mar 2014
Published By: 9Dimen Research

Price: $2850
2014 Market Research Report on Global AMOXICILLIN SODIUM Industry
was a professional and depth research report on Global AMOXICILLIN SODIUM industry that you would know the world's major regional market conditions of AMOXICILLIN SODIUM industry, the main region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc.The report firstly introduced AMOXICILLIN SODIUM basic information including AMOXICILLIN SODIUM definition classification application and industry chain overview; AMOXICILLIN SODIUM industry policy and plan, AMOXICILLIN SODIUM product specification, manufacturing process, cost structure etc. Then we deeply analyzed the world's main region market conditions that including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth r
Published Date: Mar 2014
Published By: 9Dimen Research

Price: $2850
2014 Market Research Report on Global T-Octylammonium Clavulanate Industry
was a professional and depth research report on Global T-Octylammonium Clavulanate industry that you would know the world's major regional market conditions of T-Octylammonium Clavulanate industry, the main region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc.The report firstly introduced T-Octylammonium Clavulanate basic information including T-Octylammonium Clavulanate definition classification application and industry chain overview; T-Octylammonium Clavulanate industry policy and plan, T-Octylammonium Clavulanate product specification, manufacturing process, cost structure etc. Then we deeply analyzed the world's main region market conditions that including the product price, profit, capacity, production, capa
Published Date: Mar 2014
Published By: 9Dimen Research

Price: $2850
2014 Market Research Report on Global Saponin Industry
was a professional and depth research report on Global Saponin industry that you would know the world's major regional market conditions of Saponin industry, the main region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc.The report firstly introduced Saponin basic information including Saponin definition classification application and industry chain overview; Saponin industry policy and plan, Saponin product specification, manufacturing process, cost structure etc. Then we deeply analyzed the world's main region market conditions that including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc.In the end, the report introduced Saponin new project SWOT
Published Date: Mar 2014
Published By: 9Dimen Research

Price: $2850
2014 Market Research Report on Global Avermectin Industry
was a professional and depth research report on Global Avermectin industry that you would know the world's major regional market conditions of Avermectin industry, the main region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc.The report firstly introduced Avermectin basic information including Avermectin definition classification application and industry chain overview; Avermectin industry policy and plan, Avermectin product specification, manufacturing process, cost structure etc. Then we deeply analyzed the world's main region market conditions that including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc.In the end, the report introduced Averme
Published Date: Mar 2014
Published By: 9Dimen Research

Price: $2850
2014 Market Research Report on Global Dexamethasone Industry
was a professional and depth research report on Global Dexamethasone industry that you would know the world's major regional market conditions of Dexamethasone industry, the main region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc.The report firstly introduced Dexamethasone basic information including Dexamethasone definition classification application and industry chain overview; Dexamethasone industry policy and plan, Dexamethasone product specification, manufacturing process, cost structure etc. Then we deeply analyzed the world's main region market conditions that including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc.In the end, the report
Published Date: Mar 2014
Published By: 9Dimen Research

Price: $2850
2014 Market Research Report on Global Meropenem Industry
was a professional and depth research report on Global Meropenem industry that you would know the world's major regional market conditions of Meropenem industry, the main region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc.The report firstly introduced Meropenem basic information including Meropenem definition classification application and industry chain overview; Meropenem industry policy and plan, Meropenem product specification, manufacturing process, cost structure etc. Then we deeply analyzed the world's main region market conditions that including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc.In the end, the report introduced Meropenem ne
Published Date: Mar 2014
Published By: 9Dimen Research

Price: $2850
2014 Market Research Report on Global Lincomycin hydrochloride Industry
was a professional and depth research report on Global Lincomycin hydrochloride industry that you would know the world's major regional market conditions of Lincomycin hydrochloride industry, the main region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc.The report firstly introduced Lincomycin hydrochloride basic information including Lincomycin hydrochloride definition classification application and industry chain overview; Lincomycin hydrochloride industry policy and plan, Lincomycin hydrochloride product specification, manufacturing process, cost structure etc. Then we deeply analyzed the world's main region market conditions that including the product price, profit, capacity, production, capacity utilization,
Published Date: Mar 2014
Published By: 9Dimen Research

Price: $2850
2014 Market Research Report on Global 7-ADCA Industry
was a professional and depth research report on Global 7-ADCA industry that you would know the world's major regional market conditions of 7-ADCA industry, the main region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc.The report firstly introduced 7-ADCA basic information including 7-ADCA definition classification application and industry chain overview; 7-ADCA industry policy and plan, 7-ADCA product specification, manufacturing process, cost structure etc. Then we deeply analyzed the world's main region market conditions that including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc.In the end, the report introduced 7-ADCA new project SWOT analys
Published Date: Mar 2014
Published By: 9Dimen Research

Price: $2850
2014 Market Research Report on Global 7-Aminocephalosporanic Acid (7-ACA) Industry
was a professional and depth research report on Global 7-Aminocephalosporanic Acid (7-ACA) industry that you would know the world's major regional market conditions of 7-Aminocephalosporanic Acid (7-ACA) industry, the main region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc.The report firstly introduced 7-Aminocephalosporanic Acid (7-ACA) basic information including 7-Aminocephalosporanic Acid (7-ACA) definition classification application and industry chain overview; 7-Aminocephalosporanic Acid (7-ACA) industry policy and plan, 7-Aminocephalosporanic Acid (7-ACA) product specification, manufacturing process, cost structure etc. Then we deeply analyzed the world's main region market conditions that including the p
Published Date: Mar 2014
Published By: 9Dimen Research

Price: $2850
2014 Market Research Report on Global 6-Aminopenicillin Acid (6-APA) Industry
was a professional and depth research report on Global 6-Aminopenicillin Acid (6-APA) industry that you would know the world's major regional market conditions of 6-Aminopenicillin Acid (6-APA) industry, the main region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc.The report firstly introduced 6-Aminopenicillin Acid (6-APA) basic information including 6-Aminopenicillin Acid (6-APA) definition classification application and industry chain overview; 6-Aminopenicillin Acid (6-APA) industry policy and plan, 6-Aminopenicillin Acid (6-APA) product specification, manufacturing process, cost structure etc. Then we deeply analyzed the world's main region market conditions that including the product price, profit, capacity
Published Date: Mar 2014
Published By: 9Dimen Research

Price: $2850
2014 Market Research Report on Global Penicillin Industrial Salt Industry
was a professional and depth research report on Global Penicillin Industrial Salt industry that you would know the world's major regional market conditions of Penicillin Industrial Salt industry, the main region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc.The report firstly introduced Penicillin Industrial Salt basic information including Penicillin Industrial Salt definition classification application and industry chain overview; Penicillin Industrial Salt industry policy and plan, Penicillin Industrial Salt product specification, manufacturing process, cost structure etc. Then we deeply analyzed the world's main region market conditions that including the product price, profit, capacity, production, capacity u
Published Date: Mar 2014
Published By: 9Dimen Research

Price: $2850
Partnerships, Licensing, Investments and M&A Deals and Trends for February 2014 in Pharmaceuticals
Investments and M&A Deals and Trends for February 2014 in Pharmaceuticals report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in February 2014. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry. Scope Analysis of the market tren
Published Date: Mar 2014
Published By: GlobalData

Price: $1000
Antibacterial Drugs Market (By Class - Aminoglycosides, B-Lactams, Tetracyclines, Sulfonamides, Quinolones/ Fluoroquinolones, Macrolides and Phenicols, and Pipeline Analysis) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
This report on antibacterial drugs market studies the current as well as future prospects of the market globally. The market for antibacterial drugs is segmented on the basis of major classes of drugs, namely, aminoglycosides, B-lactams, tetracyclines, sulfonamides, quinolones/fluoroquinolones, macrolides and phenicols. The market for these classes has been extensively analyzed on the basis of the leading drug launch, expiry, efficacy, sales revenue and geographic presence. The market size and forecast in terms of USD million for each of these classes has been provided for the period 2011 to 2019, considering 2012 as the base year. The report on antibacterial drugs market also provides % compounded annual growth rate (CAGR) for each market segment for the forecast period 2013 to 2019.
Published Date: Mar 2014
Published By: Transparency Market Research

Price: $4795
Membrane Technology Market in Pharmaceutical, Biopharma and Life Sciences - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2019
Membrane technology is widely used in various development phases of pharmaceutical, biopharmaceutical and life sciences industries. Membrane technology includes membrane applications from laboratory drug research to large scale pharmaceutical manufacturing. Applications of membrane technology in pharmaceutical, life sciences and biopharmaceutical industries include lab-scale DNA and protein separation and analysis, drug screening, cell culturing and examination, and virus removal. Single-use disposable technique for biopharmaceuticals and stringent environmental regulations are some of the key factors driving demand for membrane technology in pharmaceutical, biopharmaceutical and life sciences industries. Strict quality and safety standards in pharmaceutical and biopharmaceutical industrie
Published Date: Mar 2014
Published By: Transparency Market Research

Price: $4795
Partnerships, Licensing, Investments and M&A Deals and Trends for January 2014 in Pharmaceuticals
GlobalData\'s Partnerships, Licensing, Investments and M&A Deals and Trends for January 2014 in Pharmaceuticals report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in July 2013. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry. Data p
Published Date: Mar 2014
Published By: GlobalData

Price: $1000
The Pharmaceutical Market: Moldova
Moldova Pharmaceuticals & Healthcare Report Given the high level of reliance on out-of-pocket payments, the growth of the Moldova\'s pharmaceutical market is expected to be shaped by the prevailing economic conditions, both at home and abroad, on account of the importance of remittances to the country\'s GDP. For 2012, we expect the market\'s value to increase at a local currency rate of 6.7%, although this will translate into negative US dollar growth, on the back of a weak leu . Headline Expenditure Projections Pharmaceuticals: MDL2.47bn (US$211mn) in 2011 to MDL2.64bn (US$204mn) in 2012; +6.7% in local currency terms and -3.0% in US dollar terms. Forecastunchanged from Q4 12. Healthcare: MDL9.06bn (US$773mn) in 2011 to MDL9.64bn (US$747mn) in 2012; +6.4% in local currenc
Published Date: Mar 2014
Published By: Espicom

Price: $1295
The Pharmaceutical Market: Russia
OVERVIEW OF THE PHARMACEUTICAL MARKET IN RUSSIA The Russian pharmaceutical market remains a powerhouse in the Emerging Europe region . The country has by far the larg est population in the region. I ts resource s -driven economic growth is funding both private and public spending on medicines and healthcare services. The country\'s World Trade Organisation (WTO) accession has eliminated tariff barriers and should, in the long run, drive major improvements in a problematic intellectual property environment. Both domestic and cross-border mergers and acquisitions (M&A) activity has picked up since the 2009 economic crisis, a result of increased incentives for local production under the government\'s industrial policy for the sector and the need for scale to compete , especially i
Published Date: Mar 2014
Published By: Espicom

Price: $1295
The Pharmaceutical Market: Spain
OVERVIEW OF THE PHARMACEUTICAL MARKET IN SPAIN The sharp drop in public pharmaceutical expenditure in Spain in the first four months of 2012 serves as a warning for the continuation of a fall in spending on medicines in the remainder of the year. BMI notes that this does not bode well for drugmakers selling their products in Spain as the success of the implemented policies may encourage the enforcement of further cost-containment measures, which, together with the ongoing public hospital debt situation, seriously hampers the country\'s attractiveness as a location in which to sell drugs, despite its favourable demographic characteristics. Headline Expenditure Projections Pharmaceuticals: EUR20.15bn (US$28.00bn) in 2011 to EUR18.34bn (US$23.30bn) in 2012; -9.0% in local curre
Published Date: Mar 2014
Published By: Espicom

Price: $1295
The Pharmaceutical Market: United Kingdom
OVERVIEW OF THE PHARMACEUTICAL MARKET IN UNITED KINGDOM Drugmakers and governments will increasingly enter agreements that provide some form of risk- sharing or price protection for new drugs. Since most European governments, including the UK authorities, are focussing on cost containment in the healthcare sector, alternative pricing schemes for medicines allow for budget control, as well as providing patients with access to highly innovative treatments. Guidance drafted by the National Institute for Health and Clinical Excellence (NICE) has recommended the use of Bristol-Myers Squibb \'s Yervoy (ipilimumab) and Roche\'s Zelboraf ( vemurafenib) for the treatment of advanced skin cancer. These are the first new drugs approved for routine use by the UK\'s National Health Service for the
Published Date: Mar 2014
Published By: Espicom

Price: $1295
The Pharmaceutical Market: India
OVERVIEW OF THE PHARMACEUTICAL MARKET IN INDIA The outlook for India\'s patented drug market is not promising. The primary reason why sales of these products will not grow swiftly is the country\'s intellectual property (IP) regime, which is well below international standards. It does not recognise incremental improvements and as such few medicines receive exclusivity. The outlook is also restricted by the government\'s apparent desire to spend as little as possible on medical services. Whileprudenceis virtuous in an indebted global economy, India still needs to spend the \'market rate\' for healthcare infrastructure, doctors, nurses, medical devices and innovative pharmaceuticals. Without the necessary therapeutics, healthcare rofessionals, hospitals andclinics, India\'s healthcare i
Published Date: Mar 2014
Published By: Espicom

Price: $1295
The Pharmaceutical Market: Finland
OVERVIEW OF THE PHARMACEUTICAL MARKET IN FINLAND The macroenvironment for the Finnish pharmaceutical industry is improving.Politically, the new six-party coalition is larger and represents a broader spectrum of opinion than is usual, which could make it unstable. However, the Economist Intelligence Unit (EIU) believes that it will last out its four-year term. Economically, recovery from the downturn is stalling due to the euro area debt crisis. Legally, Finland remains on the USTR’s Watch List in 2011 due to concerns over patent protection. Demographically, Finland has one of the largest proportions of population over the age of 65 in Western Europe. Latest projections expect that the population aged 65 and over will constitute more than one-fifth of the total population by 2017
Published Date: Mar 2014
Published By: Espicom

Price: $1295
The Pharmaceutical Market: Belarus
Pharmaceuticals & Healthcare Report We remain largely pessimistic about the Belarus\' pharmaceutical market development in the short term at least. While the government remains committed to boosting domestic pharmaceutical output over the coming years, with authorities in manufacturing joint venture (JV) discussions with a number of countries, the devalued rouble, high inflation and weak household consumption will continue to constrain both volume and value of medicines consumed in the country. We also note increased political and also economic risks, as the country aligns itself away from the European Union (EU). Headline Expenditure Projections: Pharmaceuticals: BYR3,598bn in 2011 (US$692mn) to BYR5,623bn (US$686mn) in 2012; +56.3% in local currency terms and -1.0% in
Published Date: Mar 2014
Published By: Espicom

Price: $1295
The Pharmaceutical Market: Israel
THE PHARMACEUTICAL MARKET: ISRAEL- REVIEW Although Israel claims its very efficient healthcare system means it does not need to spend as much of its GDP on provision (some 7.6% was spent on this purpose in 2011), in reality the government\'s fiscal austerity and sick funds traditionally keep the most expensive innovative drugs and treatments unavailable. Additionally, as healthcare providers are prohibited from taking on debt, the shortage means that cheaper generics and low staff salaries have to be used to control overall costs, which often comes at the expense of services provided to patients. However, the recent ruling means that the state must increase payments to healthcare providers in order to account for rising costs, which provide some upside risks to healthcare forecasts.&n
Published Date: Mar 2014
Published By: Espicom

Price: $1295
The Pharmaceutical Market: Switzerland
OVERVIEW OF THE PHARMACEUTICAL MARKET IN SWITZERLAND While the patent cliff and the consequent availability of generic drugs, as well as price cuts on generic medicines and their increasing affordability, will work towards increasing the consumption of generic medicines in Switzerland, BMI believes the government needs to do more to alter patients\' attitudes towards these drugs as this the main deterrent of growth. Headline Expenditure Projections Pharmaceuticals: CHF6.77bn (US$7.63bn) in 2011 to CHF6.58bn (US$7.00bn) in 2012; -2.8% decline in local currency terms and -8.2% in US dollar terms. Healthcare: CHF65.30bn (US$73.6bn) in 2011 to CHF67.42bn (US$71.72bn) in 2012; +3.2% growth in local currency terms and -2.6% in US dollar terms. Medical devices: CHF4.77bn (US$5.38
Published Date: Mar 2014
Published By: Espicom

Price: $1295
The Pharmaceutical Market: Brazil
OVERVIEW OF THE PHARMACEUTICAL MARKET IN BRAZIL The Brazilian pharmaceutical market remains our favourite regional market in Latin America due to its large market size and strong domestic demand for innovative, high-tech products. The government i s increasing ly invest ing in the healthcare sector and pharmaceutical industry to reduce the financial burden of diseases , and the country\'s private healthcare sectors provide opportunities for foreign companies. However, the increasing d rug rebate level has significantly undermined the profits recorded by generic drugmakers. The more aggressive government techonology transfer deals with multinationals as well as the drug approval delays due to bureaucracy and staff shortages at ANVISA have also dampened multinationals\' revenue-generati
Published Date: Mar 2014
Published By: Espicom

Price: $1295
The Pharmaceutical Market: Kuwait
Kuwait Pharmaceuticals & Healthcare Report Kuwait\'s small population, and the fact that many residents are expatriates means that the country\'s healthcare market is closely linked to that of neighbouring Arab nations. Private healthcare accounts for around a fifth of total spending, and the government funds treatment for many nationals abroad. As Kuwait\'s population expands, grows older, and the incidence of non-communicable diseases such as diabetes and obesity increases, the government is coming under increasing pressure to improve its domestic facilities. In 2010 it embarked on a US$108bn project to add 3,500 beds to hospitals and boost healthcare facilities; once completed, the government estimates it will need an additional 15,000 healthcare professionals in the country.
Published Date: Mar 2014
Published By: Espicom

Price: $1295
The Pharmaceutical Market: Malaysia
OVERVIEW OF THE PHARMACEUTICAL MARKET IN MALAYSIA Malaysia \' s healthcare sector is showing strong signs of growth, with increased internal and investment in pharmaceutical manufacturing facilities in a move to boost exports. Key growth areas include biotechnology; namely drug discovery, new product development , technology acquisition and licensing ; generic drug production; and the recent release of h alal pharmaceutical guidelines mean s Malaysia has the potential to take a le ading role in the fast-growing h alal pharmaceutical market. While concerns remain regarding intellectual property - Malaysia has presented objections to elements in the Trans-Pacific Partnership Agreement - it is making progress in terms of trade relations: the government began negotiations over the creatio
Published Date: Mar 2014
Published By: Espicom

Price: $1295
The Pharmaceutical Market: Portugal
OVERVIEW OF THE PHARMACEUTICAL MARKET IN PORTUGAL Portugal \'s pharmaceutical and healthcare sector has been transformed since the intervention of the EU, IMF and ECB as part of the country\'s EUR78bn economic rescue package approved in May 2011 . The latest review states that Portugal has already made considerable savings in the healthcare sectors, with changes such as the introduction of e-prescriptions and prescribing by active ingredients, changes to reference pricing, reductions in pharmacy margins and price cuts just some of the measures in place. The impact on the market has been widespread. Spending has been slashed and both domestic and multinational pharmaceutical firms have seen their profits shr i nk. Data recently published by Infarmed show that Portugal has dropped from
Published Date: Mar 2014
Published By: Espicom

Price: $1295
China Chinese Patent Medicine Industry Report, 2013 - 2016
Chinese patent medicine refers to the certain dosage forms of medicine, under the guidance of TCM (traditional Chinese medicine) theory, made from traditional Chinese medicinal materials in accordance with specified prescription and standard. Chinese patent medicine industry covers the upstream Chinese herbal medicine production and preliminary processing, the middle pharmaceutical sectors as well as downstream commercial institutions of drug circulation and sales. Currently, the State is enhancing its support for the Chinese patent medicine industry, successively introducing the Continuing Improving TCM Healthcare Policy, Notice on Conducting Construction of Key Projects of TCM Trade in Services and other favorable policies in 2013. In 2010-2013, China’s Chinese patent medicine i
Published Date: Mar 2014
Published By: Research In China

Price: $2200
The Pharmaceutical Market: Egypt
OVERVIEW OF THE PHARMACEUTICAL MARKET IN EGYPT As anticipated by BMI, Egyptian President Mohammad Morsi\'s relative success in his first100days in officehighlights a degree of political and economic stability,which we believehas resulted in a final resolution of the medicines pricing system. We highlight that our expectation of the government imposing pharmaceutical price caps and adopting a controlled, low-pricing strategy has played out. The new pricing systemsets theprices of medicines higher than the old cost-plus system and BMImaintains this will be good for multinational companies in the mediumterm. However, the dangers of a possible downward pricing spiral, due to the interdependence of countries in the reference pricing basket, is along-term risk to multinationals\'revenues.
Published Date: Mar 2014
Published By: Espicom

Price: $1295
The Pharmaceutical Market: Iran
OVERVIEW OF THE PHARMACEUTICAL MARKET IN IRAN We caution that our forecasts for the Iranian pharmaceutical market are at considerable risk due to runaway inflation and political risks. We also point out that the official exchange rate does not follow the trends in the black market, which further distorts market valuations. While our local currency forecast for the market\'s development is broadly in line with the previous quarter\'s figure, the value in US dollar terms will be considerably impacted by rising inflation, caused by the sanction induced currency crisis. At the same time, we expect that the volume of pharmaceutical sales in the country will continue to be negatively impacted by the prevailing economic and political conditions. These have already resulted in shortages of c
Published Date: Mar 2014
Published By: Espicom

Price: $1295
The Pharmaceutical Market: Peru
OVERVIEW OF THE PHARMACEUTICAL MARKET IN PERU We have recently revised downwards our 2012 pharmaceutical sales growth for Peru, due to the recent price cuts in the prescription drug sector, which accounts for over 74% of total pharmaceutical sales. Still, our projected compound annual growth rate (CAGR) between 2011 and 2016 remains largely unchanged as BMI believes Peru still offers considerable longer-term benefits to local and foreign pharmaceutical companies because of the country\'s ageing population, increasing disease burden and the expected change in drug consumption patterns. Headline Expenditure Projections Pharmaceuticals: PEN3.90bn (US$1.42bn) in 2011 to PEN4.11bn (US$1.57bn) in 2012; +5.3% in local currency terms and +10.4% in US dollar terms. Forecast revised d
Published Date: Mar 2014
Published By: Espicom

Price: $1295
The Pharmaceutical Market: France
OVERVIEW OF THE PHARMACEUTICAL MARKET IN FRANCE France\\\'s high public debt-to-GDP ratio will necessitate more aggressive fiscal tightening by the state. This includestargeting the pharmaceuticals and healthcare sector, whichcurrentlyreceivesa large proportion of public funds. Headline Expenditure Projections Pharmaceuticals: EUR35.01bn (US$48.66bn) in 2011 to EUR34.17bn (US$43.39bn) in 2012. -2.4% in local currency terms and -10.8% in US dollar terms. Local currency forecast broadly unchanged from Q3 12. Healthcare: EUR234.30bn (US$325.68bn) in 2011 to EUR239.29bn (US$303.89bn) in 2012; +2.1% in local currency terms and -6.7% in US dollar terms. Local currency forecastslightly lower from Q312on account of worsening macroeconomic environment. Medical devices: EUR10.72bn
Published Date: Mar 2014
Published By: Espicom

Price: $1295
The Pharmaceutical Market: Belgium
OVERVIEW OF THE PHARMACEUTICAL MARKET IN BELGIUM We remain less than optimistic about the short- term growth of the Belgian pharmaceutical market. Through to 2016, the market\'s value is expected to post a negative compound annual growth rate (CAGR) of -1% in both local currency and US dollar terms, largely on account of cost containment measures and patent expirations. Nevertheless, foreign companies are expected to continue using Belgian pr oduction sites for exports, the country also being a popular re-export source. Headline Expenditure Projections Pharmaceuticals: EUR6.12bn (US$8.51bn) in 2011 to EUR5.96bn (US$7.57bn) in 2012; -2.6% in local currency terms and -11.0% in US dollar terms. Local currency forecast broadly unchanged from Q412. Healthcare: EUR38.96bn (US$54.
Published Date: Mar 2014
Published By: Espicom

Price: $1295
The Pharmaceutical Market: Philippines
THE PHARMACEUTICAL MARKET: PHILIPPINES - REVIEW The Philippine economy expanded by an impressive 5.9% year-on-year in Q2 12 due to strong growth from various sectors, such as services and exports. Consequently, we have upgraded the pharmaceutical market forecast. We continue to hold our view that pharmaceutical firms will see short-term opportunities in the Philippines due to ineffective governance of the prices of drugs. Headline Expenditure Projections Pharmaceuticals: PHP126.04bn (US$2.91bn) in total sales in 2011, rising to PHP129.96bn (US$2.89bn) in 2012; +3.1% in local currency terms and +3.3% in US dollar terms. Forecastup slightlyfrom Q412due to improved macroeconomic outlook. Healthcare: PHP364.95bn (US$8.43bn) in sales in 2011 rising to PHP408.26bn (US$9.45bn) in
Published Date: Mar 2014
Published By: Espicom

Price: $1295
The Pharmaceutical Market: Uganda
OVERVIEW OF THE PHARMACEUTICAL MARKET IN UGANDA While geographic diversification and investment into the pharmaceutical and healthcare sector of emerging economies such as Uganda may be a favourable strategy for any multinational pharmaceutical company - it is vital that a company recognises both the rewards and the risks present in a market. With regards to assessing risks in the Ugandan healthcare sector, we have identified industry specific dangers (such as low per-capita spending and poor access to healthcare facilities) and those emanating from the state\'s political/economic profile (such as high inflation) that call into question the likelihood of anticipated returns being realised over the assessed time period. Headline Expenditure Projections Pharmaceuticals: UGX676bn (
Published Date: Mar 2014
Published By: Espicom

Price: $1295
The Pharmaceutical Market: Ukraine
OVERVIEW OF THE PHARMACEUTICAL MARKET IN UKRAINE Foreign and domestic drugmakers in Ukraine will see their operating margins squeezed from2013as the Ministry of Health introduces more severe limitson mark-ups. Combined with the likely devaluation of the hryvnia, these factors represent a very large business risk for international drugmakers operating in the country. While Ukraine remains one of Central and Eastern Europe (CEE)\'s more promising pharmaceutical markets given its favourable demographics and disease profile, its chronic lack of economic and political stability remains a critical impediment to fulfilling this potential. Headline Expenditure Projections Pharmaceuticals: UAH26.75bn (US$3.35bn) in 2011 to UAH30.79bn (US$3.75bn) in 2012; +15.1% in local currency term
Published Date: Mar 2014
Published By: Espicom

Price: $1295
The Pharmaceutical Market: Zimbabwe
Zimbabwe Pharmaceuticals & Healthcare Report Regardless of the outcome of the upcoming general elections, scheduled for November 2012, we remain pessimistic about the short - to medium - term development of Zimbabwe\'s pharmaceutical market. While the need for medicines is vast, the majority of demand continues to be met through foreign donations, indicating the dire situation in the country. At the same time, the domestic industry continues to struggle, without much hope for government finances or credit extensions, which will continue to exacerbate the already massive problems with regard to access to medicines. Headline Expenditure Projections Pharmaceuticals: US$160mn in 2011 to US$180mn in 2012; +12.7% in US dollar terms. Forecast in line with Q3 12. Healthcare US$
Published Date: Mar 2014
Published By: Espicom

Price: $1295
Partnering Deals and Alliances with Big Pharma
The Partnering Deals and Alliances with Big Pharma report provides the most comprehensive and in-depth insight into the dealmaking interests and activity of the worlds leading fifty big pharma companies.   Partnering Deals and Alliances with Big Pharma provides the user with the following key benefits:   Detailed partnering activity profiles for each of the top 50 big pharma companies Over 300 charts showing a company’s dealmaking activity since 2007, allowing quick identification potential partners Partnering therapy focus revealed Partnering activity since 2009 – number of deals per year Full listing of partnering deals Activity by deal type Activity by industry sector Activity by phase of development Activity by technology type Activity by th
Published Date: Mar 2014
Published By: Current Partnering

Price: $3295
Discovery, Preclinical and Clinical Stage Partnering Terms and Agreements in Pharma and Biotech
The Discovery, Preclinical and Clinical Stage Partnering Terms and Agreements in Pharma and Biotech report provides comprehensive understanding and unprecedented access to the discovery, preclinical and clinical stage partnering deals and agreements entered into by the worlds leading healthcare companies.   The report provides a detailed understanding and analysis of how and why companies enter discovery, preclinical and clinical stage partnering deals. The majority of deals are where the licensee obtains a right or an option right to license the licensors product or compound. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.   Understanding the flexibility of a prospective partner’s negotiated deals terms pro
Published Date: Mar 2014
Published By: Current Partnering

Price: $5495
The Pharmaceutical Market: Singapore
OVERVIEW OF THE PHARMACEUTICAL MARKET IN SINGAPORE Singapore will be of moderate attractiveness to investors given its small pharmaceutical market size, despite the growing demands for more pharmaceuticals and healthcare from its increasingly ageing population. However, the city-state will continue to attract companies looking to set up regional offices, manufacturing hubs or research and development facilities in the country given its strong regulatory framework and relatively stable political and economic environment. Headline Expenditure Projections Pharmaceuticals: SGD901mn (US$716mn) in 2011 to SGD942mn (US$751mn) in 2012; +4.5% in local currency terms and +4.9% in US dollar terms. Forecast broadly in line with previous quarter. Healthcare: SGD13.1bn (US$10.4bn) in 201
Published Date: Mar 2014
Published By: Espicom

Price: $1295
Pharmacovigilance Market [Clinical Trial Phases (Pre-Clinical Studies, Phase I, Phase II, Phase III, Phase IV or Post-Marketing Surveillance) and Service Providers (In-House and Contract Outsourcing] - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
A rising tide of regulatory expectations, tougher inspection regime and instant need of patient reporting has provided the much needed impetus for the growth of the pharmacovigilance market. An upsurge in number of acute and chronic diseases has consequently led to a rise in number of drug consumption, which has also elicited a growth in the number of adverse drug events and drug toxicity cases. Moreover, several high-profile safety issues, regulatory warnings, large volume of events to be reviewed along with negative media coverage have compelled the pharmaceutical players to take support of various outsourcing services. There are two major outsourcing services opted by these pharmaceutical players i.e. traditional CROs and BPOs. These outsourcing services not only provide cost savings
Published Date: Mar 2014
Published By: Transparency Market Research

Price: $4795
Pharmaceutical Industry in China - Cutting-Edge Analysis of Multinational and Chinese Pharma Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, Opportunities & Challenges
Pharmaceutical Industry China – Cutting-Edge Analysis of Multinational and Chinese Biopharma Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, Opportunities & Challenges” provides you with a detailed investigation of the market size, segmentation, key players, SWOT analysis, influential Government policies, and business and economic environments. The report is supported by over 199 tables & figures within 153 pages. The Chinese biopharmaceutical market is presented as follows: By Company (e.g., AMOYTOP BIOTECH, BEIJING CONTINENT PHARMACEUTICALS, FUSOGEN, SHANGHAI HUAGUAN BIOCHIP, SIBIONO GENETECH, ABBOTT, ROCHE, PFIZER, GSK, NOVARTIS) By Therapeutic Area (e.g., Anti-infective, Cancer, Diabetes, Dementia, Depression) A weal
Published Date: Mar 2014
Published By: Kelly Scientific Publications

Price: $2754
Global and China Dropper Industry 2014 Market Research Report
The report firstly introduced Dropper basic information included Dropper definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Dropper industry policy and plan, Dropper product specification, manufacturing process, product cost structure etc. then statistics Global and China key manufacturers Dropper capacity production cost price profit production value gross margin etc details information, at the same time, statistics these manufacturers Dropper products customers application capacity market position company contact information etc company related information, then collect all these manufacturers data and listed Global and C
Published Date: Feb 2014
Published By: QYResearch

Price: $2200
Investigation Report on China Tacrolimus Market, 2009 - 2018
Tacrolimus, also named as \"FK506\" and \"FR-900506\", was developed by Fujisawa Pharmaceutical Co., Ltd. (later became Astellas Pharma by merging with Yamanouchi Pharmaceutical Co., Ltd.). In June 1993, it was firstly approved to Japan with the trade name \"Prograf\". Tacrolimus is an immunosuppressive drug that is used mainly after allogeneic organ transplant to reduce the activity of the patient\'s immune system and so lower the risk of organ rejection. It was approved by the FDA in 1994. Tacrolimus is sold in markets of several countries and regions now. In 1998, tacrolimus preparation (injection and capsule) was approved to import into China.  Since then, tacrolimus has become a first-line clinical drug to reduce organ rejection after liver and kidney transplantation in China.
Published Date: Feb 2014
Published By: China Research and Intelligence Co., Ltd. (CRI)

Price: $1800